Neuroprotective effects of the PPARβ/δ antagonist GSK0660 in in vitro and in vivo Parkinson's disease models.
- Published in:
- Biological Research, 2023, v. 56, n. 1, p. 1, doi. 10.1186/s40659-023-00438-1
- By:
- Publication type:
- Article
Works matching AU Alfonsetti, Margherita
Results: 12
1
2
The Influence of Dietary Supplementations on Neuropathic Pain.
- Published in:
- Life (2075-1729), 2022, v. 12, n. 8, p. 1125, doi. 10.3390/life12081125
- By:
- Publication type:
- Article
3
Neurotrophic factor-based pharmacological approaches in neurological disorders.
- Published in:
- Neural Regeneration Research, 2023, v. 18, n. 6, p. 1220, doi. 10.4103/1673-5374.358619
- By:
- Publication type:
- Article
4
A novel human organoid model system reveals requirement of TCF4 for oligodendroglial differentiation.
- Published in:
- Life Science Alliance, 2025, v. 8, n. 6, p. 1, doi. 10.26508/lsa.202403102
- By:
- Publication type:
- Article
5
S-Carboxymethyl Cysteine Protects against Oxidative Stress and Mitochondrial Impairment in a Parkinson's Disease In Vitro Model.
- Published in:
- Biomedicines, 2021, v. 9, n. 10, p. 1467, doi. 10.3390/biomedicines9101467
- By:
- Publication type:
- Article
6
PPARα-Selective Antagonist GW6471 Inhibits Cell Growth in Breast Cancer Stem Cells Inducing Energy Imbalance and Metabolic Stress.
- Published in:
- Biomedicines, 2021, v. 9, n. 2, p. 127, doi. 10.3390/biomedicines9020127
- By:
- Publication type:
- Article
7
Neuroprotective potential of choline alfoscerate against β‐amyloid injury: Involvement of neurotrophic signals.
- Published in:
- Cell Biology International, 2020, v. 44, n. 8, p. 1734, doi. 10.1002/cbin.11369
- By:
- Publication type:
- Article
8
Differential Effects of Nonsteroidal Anti-Inflammatory Drugs in an In Vitro Model of Human Leaky Gut.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 5, p. 728, doi. 10.3390/cells12050728
- By:
- Publication type:
- Article
9
CXCR1/2 Inhibitor Ladarixin Ameliorates the Insulin Resistance of 3T3-L1 Adipocytes by Inhibiting Inflammation and Improving Insulin Signaling.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 9, p. 2324, doi. 10.3390/cells10092324
- By:
- Publication type:
- Article
10
Looking for In Vitro Models for Retinal Diseases.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 19, p. 10334, doi. 10.3390/ijms221910334
- By:
- Publication type:
- Article
11
Are We What We Eat? Impact of Diet on the Gut–Brain Axis in Parkinson's Disease.
- Published in:
- Nutrients, 2022, v. 14, n. 2, p. 380, doi. 10.3390/nu14020380
- By:
- Publication type:
- Article
12
L-Methionine Protects against Oxidative Stress and Mitochondrial Dysfunction in an In Vitro Model of Parkinson's Disease.
- Published in:
- Antioxidants, 2021, v. 10, n. 9, p. 1467, doi. 10.3390/antiox10091467
- By:
- Publication type:
- Article